BioSpace News Archive

The BioCode® SARS-CoV-2 Assay is a multiplex nucleic acid assay for the qualitative detection of SARS-CoV-2 nucleic acids in nasopharyngeal swabs and bronchoalveolar lavage.

PPD, Inc. (Nasdaq:PPD), a leading global contract research organization, today announced it will release its first quarter 2020 results after market close on Wednesday, May 6, 2020.

BioSig Technologies, Inc. (Nasdaq: BSGM) today announced that an article titled, “The IMPDH inhibitor merimepodib has similar antiviral activity against SARS-CoV-2 replication in vitro to the adenosine analogue remdesivir” was accepted by F1000 Research, an online peer-reviewed life sciences journal publishing program in biology and medicine.

Sengenics, a functional proteomics company, today announced the product launch of a new KREX™-based array, the ImmuKyne™ protein array, in a bid to enhance and accelerate effective response for COVID-19 by understanding whether autoantibodies play a role in progression to severe disease in COVID-19 patients, using advanced antibody profiling assays.

ProThera Biologics, Inc. and Takeda Pharmaceutical Company Limited [TSE:4502/NYSE:TAK] (“Takeda”) today announced that they have entered into a global licensing agreement to develop a novel plasma-derived Inter-alpha Inhibitor Proteins (IAIP) therapy for the treatment of acute inflammatory conditions.

The National Association of Specialty Pharmacy (NASP), a nonprofit organization representing specialty pharmacy industry stakeholders, named former NFL quarterback and Pro Football Hall of Fame member Jim Kelly as a keynote speaker for the 2020 NASP Annual Meeting & Expo.

Shanghai Henlius Biotech, Inc. (2696.HK) announced that the company’s drug substance (DS) line and drug product (DP) line for HLX02 trastuzumab biosimilar have successfully passed the European United (EU) Good Manufacturing Practice (GMP) on-site inspection and the company has received two EU GMP Certificates (Certificate of GMP Compliance of a Manufacturer) from Poland’s Chief Pharmaceutical Inspector.

Elysium Health, Inc.™, a life sciences company developing clinically validated health products based on advancements in scientific research, has entered into an exclusive partnership with Yale University to license DNA methylation biomarkers of personalized health and aging and cellular senescence developed by Morgan Levine, Ph.D., assistant professor at the Yale School of Medicine.

America’s biopharmaceutical companies have recently reiterated that they are committed to developing solutions to help diagnose and treat those with COVID-19, a disease caused by a novel strain of coronavirus.

AliveCor, a leader in personal ECG products, and OMRON Healthcare, Co., Ltd., a global leader in personal heart health and wellness technology, today announced a global, strategic alliance that combines AliveCor’s ECG technology with industry-leading blood pressure devices from OMRON to better serve customers and expand access to remote patient care